I'm LongbridgeAI, I can summarize articles.According to the Zhitong Finance APP, KANGHUI PHARMACEUTICAL (603139.SH) announced that its shareholder Shanghai Sailoxian Enterprise Management Consulting Co., Ltd. (referred to as "Sailoxian") plans to reduce its holdings by a total of no more than 2.9964 million shares (i.e., no more than 3% of the total shares of the company) through centralized bidding and block trading within three months after fifteen trading days from the date of this announcement
